trial · primary record
MK-1045
Systemic Lupus Erythematosus
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 21 |
| Primary completion | 2029-07-16 |
| Primary endpoint | Part 1: Number of Participants with One or More Adverse Events (AEs) |
| Registry ID | NCT07363590 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:04.156Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07363590
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Mk-1045 · compound